المؤلفون: Salvaris R., Opat S.

مصطلحات الفهرس: drug safety, drug tolerability, dyspnea/si [Side Effect], febrile neutropenia/si [Side Effect], fever/si [Side Effect], human, infection/si [Side Effect], infestation/si [Side Effect], infusion related reaction/dt [Drug Therapy], infusion related reaction/si [Side Effect], monotherapy, nausea/si [Side Effect], neutropenia/si [Side Effect], pharmacodynamic parameters, pharmacokinetic parameters, pharmacological parameters, phase 3 clinical trial (topic), pneumonia/si [Side Effect], priority journal, pruritus/si [Side Effect], rigor/si [Side Effect], tachycardia/si [Side Effect], thrombocytopenia/si [Side Effect], tumor lysis syndrome/si [Side Effect], acalabrutinib/cb [Drug Combination], acalabrutinib/dt [Drug Therapy], bendamustine/dt [Drug Therapy], chlorambucil/ae [Adverse Drug Reaction], chlorambucil/cb [Drug Combination], chlorambucil/dt [Drug Therapy], clarithromycin/it [Drug Interaction], cyclophosphamide/cb [Drug Combination], cyclophosphamide/cm [Drug Comparison], cyclophosphamide/dt [Drug Therapy], fludarabine/cb [Drug Combination], fludarabine/cm [Drug Comparison], fludarabine/dt [Drug Therapy], hydrocortisone/dt [Drug Therapy], ibrutinib/cb [Drug Combination], ibrutinib/cm [Drug Comparison], ibrutinib/dt [Drug Therapy], obinutuzumab/cb [Drug Combination], obinutuzumab/dt [Drug Therapy], posaconazole/it [Drug Interaction], ritonavir/it [Drug Interaction], rituximab/ae [Adverse Drug Reaction], rituximab/cb [Drug Combination], rituximab/cm [Drug Comparison], rituximab/dt [Drug Therapy], venetoclax/ae [Adverse Drug Reaction], venetoclax/cb [Drug Combination], venetoclax/cm [Drug Comparison], venetoclax/it [Drug Interaction], venetoclax/dt [Drug Therapy], obinutuzumab/ae [Adverse Drug Reaction], abdominal pain/si [Side Effect], allogeneic hematopoietic stem cell transplantation, anemia/si [Side Effect], article, backache/si [Side Effect], cancer chemotherapy, cancer immunotherapy, cancer recurrence, chronic lymphatic leukemia/dt [Drug Therapy], chronic lymphatic leukemia/th [Therapy], diarrhea/si [Side Effect], drug efficacy, drug metabolism, drug potentiation, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/27245
Future Oncology
Click here for full text options
LibKey Link

المؤلفون: Sanz R.G., Tam C.S., Opat S., D'Sa S., Jurczak W., Lee H.-P., Cull G., Owen R.G., Marlton P., Ewahlin B., Motta M., Siddiqi T., Tani M., Trneny M., Minnema M.C., Buske C., Leblond V., Trotman J., Chan W.Y., Schneider J., Ro S., Cohen A., Huang J., McCarthy H., Mulligan S., Tedeschi A., Castillo J.J., Czyz J., De Larrea C.F., Belada D., Libby E., Matous J.V.

مصطلحات الفهرس: nausea/si [Side Effect], neutropenia, nuclear magnetic resonance imaging, open study, overall survival, patient-reported outcome, peripheral edema, peripheral neuropathy/si [Side Effect], phase 3 clinical trial, pneumonia, priority journal, progression free survival, quality of life, quantitative analysis, randomized controlled trial, rash/si [Side Effect], sepsis/si [Side Effect], skin cancer/si [Side Effect], subdural hematoma/si [Side Effect], thrombocytopenia/si [Side Effect], treatment duration, treatment interruption, treatment response, tumor lysis syndrome/si [Side Effect], tumor volume, upper respiratory tract infection/si [Side Effect], urinary tract infection/si [Side Effect], vomiting/si [Side Effect], Waldenstroem macroglobulinemia/di [Diagnosis], Waldenstroem macroglobulinemia/dm [Disease Management], Waldenstroem macroglobulinemia/dt [Drug Therapy], beta 2 microglobulin/ec [Endogenous Compound], chemokine receptor CXCR4/ec [Endogenous Compound], hemoglobin/ec [Endogenous Compound], ibrutinib/ae [Adverse Drug Reaction], ibrutinib/ct [Clinical Trial], ibrutinib/cm [Drug Comparison], ibrutinib/dt [Drug Therapy], ibrutinib/pd [Pharmacology], ibrutinib/pv [Special Situation for Pharmacovigilance], immunoglobulin A/ec [Endogenous Compound], immunoglobulin G/ec [Endogenous Compound], immunoglobulin M/ec [Endogenous Compound], myeloid differentiation factor 88/ec [Endogenous Compound], zanubrutinib/ae [Adverse Drug Reaction], zanubrutinib/ct [Clinical Trial], zanubrutinib/cm [Drug Comparison], zanubrutinib/dt [Drug Therapy], zanubrutinib/pd [Pharmacology], zanubrutinib/pv [Special Situation for Pharmacovigilance], immunoglobulin A multiple myeloma/si [Side Effect], computer assisted tomography, backache/si [Side Effect], bacteremia/si [Side Effect], blood viscosity, bone marrow biopsy, cancer chemotherapy, cohort analysis, comorbidity, adverse drug reaction/si [Side Effect], aged, anemia/si [Side Effect], arthralgia/si [Side Effect], article, comparative effectiveness, atrial fibrillation/si [Side Effect], constipation/si [Side Effect], contrast enhancement, controlled study, contusion, diarrhea, drug induced disease/si [Side Effect], drug safety, dyspnea/si [Side Effect], European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30, fatigue/si [Side Effect], female, fever/si [Side Effect], headache/si [Side Effect], heart arrest/si [Side Effect], heart infarction/si [Side Effect], hematuria/si [Side Effect], hemoglobin blood level, hemoglobin determination, hepatitis/si [Side Effect], high throughput sequencing, human, hypertension/si [Side Effect], interstitial lung disease/si [Side Effect], liver injury/si [Side Effect], major clinical study, male, Mantel Haenszel test, missense mutation, multiple myeloma/si [Side Effect], muscle spasm, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/26832
Blood
Click here for full text options
LibKey Link

المؤلفون: Marraffa C., May T., Williams K., Brignell A., Prakash C.

مصطلحات الفهرس: functional status, gastrointestinal symptom/si [Side Effect], headache/si [Side Effect], health status, human, hyperactivity, hypertension/si [Side Effect], irritability, nausea/si [Side Effect], neurologic disease/si [Side Effect], priority journal, quality of life, randomized controlled trial (topic), social interaction, somnolence/si [Side Effect], cognition, constipation/si [Side Effect], autism/dt [Drug Therapy], autism assessment, Autism Diagnostic Interview Revised, Autism Diagnostic Observation Schedule, cardiovascular disease/si [Side Effect], Childhood Autism Rating Scale, Clinical Global Impression scale, communication skill, placebo, Connors Abbreviated Parent Teacher Questionnaire, memantine/pv [Special Situation for Pharmacovigilance], stereotypy, Yale Brown Obsessive Compulsive Scale, memantine/ae [Adverse Drug Reaction], memantine/cm [Drug Comparison], memantine/dt [Drug Therapy], Diagnostic Instrument for Social Communication Disorders, aggression, article, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/26749
Cochrane Database of Systematic Reviews
Click here for full text options
LibKey Link

المؤلفون: Trotman J., Marlton P., Cull G., Munoz J., Tedeschi A., Roberts A.W., Seymour J.F., Atwal S.K., Yu Y., Novotny W., Holmgren E., Tan Z., Hilger J.D., Huang J., Tam C.S., Simpson D., Gottlieb D., Opat S.

مصطلحات الفهرس: human, hypertension/si [Side Effect], lower respiratory tract infection/si [Side Effect], major clinical study, male, nausea/si [Side Effect], neutropenia/si [Side Effect], oropharynx pain/si [Side Effect], overall response rate, overall survival, petechia/si [Side Effect], phase 1 clinical trial, phase 2 clinical trial, pneumonia/si [Side Effect], priority journal, progression free survival, pruritus/si [Side Effect], pseudallescheriasis/si [Side Effect], rash/si [Side Effect], remission, sepsis/si [Side Effect], side effect/si [Side Effect], skin cancer/si [Side Effect], stomach adenocarcinoma/si [Side Effect], thrombocytopenia/si [Side Effect], treatment response, tumor lysis syndrome/si [Side Effect], upper respiratory tract infection/si [Side Effect], Waldenstroem macroglobulinemia/dt [Drug Therapy], hemoglobin/ec [Endogenous Compound], immunoglobulin M/ec [Endogenous Compound], zanubrutinib/ae [Adverse Drug Reaction], zanubrutinib/ct [Clinical Trial], zanubrutinib/dt [Drug Therapy], multicenter study, actinic keratosis/si [Side Effect], adult, aged, anemia/si [Side Effect], arthralgia/si [Side Effect], article, atrial fibrillation/si [Side Effect], backache/si [Side Effect], bacterial arthritis/si [Side Effect], basal cell carcinoma/si [Side Effect], bleeding/si [Side Effect], bronchiectasis/si [Side Effect], cellulitis/si [Side Effect], constipation/si [Side Effect], contusion/si [Side Effect], coughing/si [Side Effect], demography, diarrhea/si [Side Effect], disease exacerbation, drug efficacy, drug safety, drug withdrawal, epistaxis/si [Side Effect], falling, fatigue/si [Side Effect], female, follow up, gastroesophageal reflux/si [Side Effect], headache/si [Side Effect], hepatitis B/si [Side Effect], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/26861
Blood
Click here for full text options
LibKey Link

المؤلفون: Redfern A.D., Kirkwood I.D., Ng S., Francis R.J., Gedye C., Rutherford N.K., Weickhardt A., Scott A.M., Lee S.-T., Kwan E.M., Azad A.A., Ramdave S., Tan T.H., Macdonald W., Guminski A., Hsiao E., Chua W., Lin P., Zhang A.Y., McJannett M.M., Stockler M.R., Violet J.A., Williams S.G., Martin A.J., Davis I.D., Dhiantravan N., Ford K., Langford A., Lawrence N., McDonald W., Rana N., Subramaniam S., Yip S., Hofman M.S., Emmett L., Sandhu S., Iravani A., Joshua A.M., Goh J.C., Pattison D.A.

مصطلحات الفهرس: radioisotope, unclassified drug, vipivotide tetraxetan lutetium lu 177/ae [Adverse Drug Reaction], vipivotide tetraxetan lutetium lu 177/ct [Clinical Trial], vipivotide tetraxetan lutetium lu 177/cm [Drug Comparison], vipivotide tetraxetan lutetium lu 177/iv [Intravenous Drug Administration], vipivotide tetraxetan lutetium lu 177/pv [Special Situation for Pharmacovigilance], 2 flourine 18 fluoro 2 deoxy dextro glucose f 18, vipivotide tetraxetan lutetium lu 177/dt [Drug Therapy], aged, anemia/si [Side Effect], article, Australia, cancer screening, cancer therapy, castration resistant prostate cancer/dt [Drug Therapy], controlled study, diarrhea/si [Side Effect], dizziness/si [Side Effect], drug efficacy, drug safety, dry eye/si [Side Effect], dysgeusia/si [Side Effect], fatigue/si [Side Effect], foot pain/si [Side Effect], hair loss/si [Side Effect], hand pain/si [Side Effect], hematology, hematuria/si [Side Effect], human, insomnia/si [Side Effect], kidney function, leukopenia/si [Side Effect], liver function, male, metastasis, multicenter study, multiple cycle treatment, nausea/si [Side Effect], neuropathy/si [Side Effect], neutropenia/si [Side Effect], pain/si [Side Effect], patient participation, phase 2 clinical trial, positron emission tomography-computed tomography, priority journal, randomized controlled trial, rash/si [Side Effect], taste disorder/si [Side Effect], thrombocytopenia/si [Side Effect], treatment outcome, treatment response, vomiting/si [Side Effect], xerostomia/si [Side Effect], cabazitaxel/ae [Adverse Drug Reaction], cabazitaxel/ct [Clinical Trial], cabazitaxel/cm [Drug Comparison], cabazitaxel/iv [Intravenous Drug Administration], cabazitaxel/pv [Special Situation for Pharmacovigilance], gallium gozetotide ga 68, prostate specific antigen/ec [Endogenous Compound], Article

URL: The Lancet
Click here for full text options
LibKey Link

المؤلفون: Salvaris R., Opat S.

مصطلحات الفهرس: drug safety, drug tolerability, dyspnea/si [Side Effect], febrile neutropenia/si [Side Effect], fever/si [Side Effect], human, infection/si [Side Effect], infestation/si [Side Effect], infusion related reaction/dt [Drug Therapy], infusion related reaction/si [Side Effect], monotherapy, nausea/si [Side Effect], neutropenia/si [Side Effect], pharmacodynamic parameters, pharmacokinetic parameters, pharmacological parameters, phase 3 clinical trial (topic), pneumonia/si [Side Effect], priority journal, pruritus/si [Side Effect], rigor/si [Side Effect], tachycardia/si [Side Effect], thrombocytopenia/si [Side Effect], tumor lysis syndrome/si [Side Effect], acalabrutinib/cb [Drug Combination], acalabrutinib/dt [Drug Therapy], bendamustine/dt [Drug Therapy], chlorambucil/ae [Adverse Drug Reaction], chlorambucil/cb [Drug Combination], chlorambucil/dt [Drug Therapy], clarithromycin/it [Drug Interaction], cyclophosphamide/cb [Drug Combination], cyclophosphamide/cm [Drug Comparison], cyclophosphamide/dt [Drug Therapy], fludarabine/cb [Drug Combination], fludarabine/cm [Drug Comparison], fludarabine/dt [Drug Therapy], hydrocortisone/dt [Drug Therapy], ibrutinib/cb [Drug Combination], ibrutinib/cm [Drug Comparison], ibrutinib/dt [Drug Therapy], obinutuzumab/cb [Drug Combination], obinutuzumab/dt [Drug Therapy], posaconazole/it [Drug Interaction], ritonavir/it [Drug Interaction], rituximab/ae [Adverse Drug Reaction], rituximab/cb [Drug Combination], rituximab/cm [Drug Comparison], rituximab/dt [Drug Therapy], venetoclax/ae [Adverse Drug Reaction], venetoclax/cb [Drug Combination], venetoclax/cm [Drug Comparison], venetoclax/it [Drug Interaction], venetoclax/dt [Drug Therapy], obinutuzumab/ae [Adverse Drug Reaction], abdominal pain/si [Side Effect], allogeneic hematopoietic stem cell transplantation, anemia/si [Side Effect], article, backache/si [Side Effect], cancer chemotherapy, cancer immunotherapy, cancer recurrence, chronic lymphatic leukemia/dt [Drug Therapy], chronic lymphatic leukemia/th [Therapy], diarrhea/si [Side Effect], drug efficacy, drug metabolism, drug potentiation, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/27245
Future Oncology
LibKey Link

المؤلفون: Sanz R.G., Tam C.S., Opat S., D'Sa S., Jurczak W., Lee H.-P., Cull G., Owen R.G., Marlton P., Ewahlin B., Motta M., Siddiqi T., Tani M., Trneny M., Minnema M.C., Buske C., Leblond V., Trotman J., Chan W.Y., Schneider J., Ro S., Cohen A., Huang J., McCarthy H., Mulligan S., Tedeschi A., Castillo J.J., Czyz J., De Larrea C.F., Belada D., Libby E., Matous J.V.

مصطلحات الفهرس: nausea/si [Side Effect], neutropenia, nuclear magnetic resonance imaging, open study, overall survival, patient-reported outcome, peripheral edema, peripheral neuropathy/si [Side Effect], phase 3 clinical trial, pneumonia, priority journal, progression free survival, quality of life, quantitative analysis, randomized controlled trial, rash/si [Side Effect], sepsis/si [Side Effect], skin cancer/si [Side Effect], subdural hematoma/si [Side Effect], thrombocytopenia/si [Side Effect], treatment duration, treatment interruption, treatment response, tumor lysis syndrome/si [Side Effect], tumor volume, upper respiratory tract infection/si [Side Effect], urinary tract infection/si [Side Effect], vomiting/si [Side Effect], Waldenstroem macroglobulinemia/di [Diagnosis], Waldenstroem macroglobulinemia/dm [Disease Management], Waldenstroem macroglobulinemia/dt [Drug Therapy], beta 2 microglobulin/ec [Endogenous Compound], chemokine receptor CXCR4/ec [Endogenous Compound], hemoglobin/ec [Endogenous Compound], ibrutinib/ae [Adverse Drug Reaction], ibrutinib/ct [Clinical Trial], ibrutinib/cm [Drug Comparison], ibrutinib/dt [Drug Therapy], ibrutinib/pd [Pharmacology], ibrutinib/pv [Special Situation for Pharmacovigilance], immunoglobulin A/ec [Endogenous Compound], immunoglobulin G/ec [Endogenous Compound], immunoglobulin M/ec [Endogenous Compound], myeloid differentiation factor 88/ec [Endogenous Compound], zanubrutinib/ae [Adverse Drug Reaction], zanubrutinib/ct [Clinical Trial], zanubrutinib/cm [Drug Comparison], zanubrutinib/dt [Drug Therapy], zanubrutinib/pd [Pharmacology], zanubrutinib/pv [Special Situation for Pharmacovigilance], immunoglobulin A multiple myeloma/si [Side Effect], computer assisted tomography, backache/si [Side Effect], bacteremia/si [Side Effect], blood viscosity, bone marrow biopsy, cancer chemotherapy, cohort analysis, comorbidity, adverse drug reaction/si [Side Effect], aged, anemia/si [Side Effect], arthralgia/si [Side Effect], article, comparative effectiveness, atrial fibrillation/si [Side Effect], constipation/si [Side Effect], contrast enhancement, controlled study, contusion, diarrhea, drug induced disease/si [Side Effect], drug safety, dyspnea/si [Side Effect], European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30, fatigue/si [Side Effect], female, fever/si [Side Effect], headache/si [Side Effect], heart arrest/si [Side Effect], heart infarction/si [Side Effect], hematuria/si [Side Effect], hemoglobin blood level, hemoglobin determination, hepatitis/si [Side Effect], high throughput sequencing, human, hypertension/si [Side Effect], interstitial lung disease/si [Side Effect], liver injury/si [Side Effect], major clinical study, male, Mantel Haenszel test, missense mutation, multiple myeloma/si [Side Effect], muscle spasm, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/26832
Blood
LibKey Link

المؤلفون: Di Somma H., Condous G., Armour S., Wong L., da Silva Costa F., Colombo G.E., Leonardi M., Armour M., Dinh T.

مصطلحات الفهرس: blood transfusion, vomiting/si [Side Effect], conjunctivitis/si [Side Effect], depression, diarrhea/si [Side Effect], female, Hospital Anxiety and Depression Scale, human, meta analysis, nausea/si [Side Effect], outcome assessment, patient preference, photosensitivity/si [Side Effect], methotrexate/im [Intramuscular Drug Administration], methotrexate/dt [Drug Therapy], methotrexate/cm [Drug Comparison], anxiety disorder, pregnancy rate, priority journal, randomized controlled trial (topic), Short Form 36, single drug dose, placebo, uterine tube pregnancy/dt [Drug Therapy], adult, article, methotrexate/ae [Adverse Drug Reaction], chorionic gonadotropin/ec [Endogenous Compound], systematic review, practice guideline, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/27038
Human Reproduction Open
LibKey Link

المؤلفون: Marraffa C., May T., Williams K., Brignell A., Prakash C.

مصطلحات الفهرس: functional status, gastrointestinal symptom/si [Side Effect], headache/si [Side Effect], health status, human, hyperactivity, hypertension/si [Side Effect], irritability, nausea/si [Side Effect], neurologic disease/si [Side Effect], priority journal, quality of life, randomized controlled trial (topic), social interaction, somnolence/si [Side Effect], cognition, constipation/si [Side Effect], autism/dt [Drug Therapy], autism assessment, Autism Diagnostic Interview Revised, Autism Diagnostic Observation Schedule, cardiovascular disease/si [Side Effect], Childhood Autism Rating Scale, Clinical Global Impression scale, communication skill, placebo, Connors Abbreviated Parent Teacher Questionnaire, memantine/pv [Special Situation for Pharmacovigilance], stereotypy, Yale Brown Obsessive Compulsive Scale, memantine/ae [Adverse Drug Reaction], memantine/cm [Drug Comparison], memantine/dt [Drug Therapy], Diagnostic Instrument for Social Communication Disorders, aggression, article, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/26749
Cochrane Database of Systematic Reviews
LibKey Link

المؤلفون: Botti M., Khaw D., Bucknall T., Considine J., Duke M., Hutchinson A., Redley B., de Steiger R.

مصطلحات الفهرس: major clinical study, male, morphine equivalent dose, nausea/si [Side Effect], obesity, observational study, osteoarthritis/su [Surgery], pain assessment, pain measurement, patient controlled analgesia, physical activity, postoperative analgesia, postoperative pain/co [Complication], postoperative pain/dt [Drug Therapy], prescription, prevalence, priority journal, private hospital, psychometry, rheumatoid arthritis/su [Surgery], sustained drug release, tertiary care center, total hip replacement, total knee arthroplasty, trend study, Victoria, adjuvant/dt [Drug Therapy], adjuvant/pv [Special Situation for Pharmacovigilance], analgesic agent/dt [Drug Therapy], nonsteroid antiinflammatory agent/cb [Drug Combination], nonsteroid antiinflammatory agent/dt [Drug Therapy], nonsteroid antiinflammatory agent/pv [Special Situation for Pharmacovigilance], opiate/ae [Adverse Drug Reaction], opiate/cb [Drug Combination], opiate/dt [Drug Therapy], opiate/pv [Special Situation for Pharmacovigilance], paracetamol/cb [Drug Combination], paracetamol/dt [Drug Therapy], paracetamol/pv [Special Situation for Pharmacovigilance], tramadol/dt [Drug Therapy], tramadol/pv [Special Situation for Pharmacovigilance], American Pain Society Patient Outcome Questionnaire, Revised American Pain Society Patient Outcome Questionnaire, female, laxative/dt [Drug Therapy], laxative/pv [Special Situation for Pharmacovigilance], analgesic agent/pv [Special Situation for Pharmacovigilance], aged, article, body mass, breakthrough pain, combination drug therapy, constipation/dt [Drug Therapy], constipation/si [Side Effect], controlled study, dizziness/si [Side Effect], drowsiness/si [Side Effect], English (language), evidence based practice, follow up, fracture/su [Surgery], health care quality, human, longitudinal study, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28711
European Journal of Pain
LibKey Link